{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:20:47Z","timestamp":1791555647280,"version":"4.3.4"},"reference-count":58,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Thyroid\u00ae"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hyperthyroidism is known to have a significant impact on quality of life (QoL), at least in the short term. The purpose of the present study was to assess QoL in patients 6\u201310 years after treatment for Graves' disease (GD) with radioiodine (RAI) compared to those treated with thyroidectomy or antithyroid drugs (ATD) as assessed with both thyroid-specific Thyroid-Related Patient-Reported Outcome (ThyPRO) questionnaire and general (36-item Short Form Health Status) QoL survey.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      The study evaluated 1186 GD patients in a sub-cohort from an incidence study 2003\u20132005 who had been treated according to routine clinical practice at seven participating centers. Patients were included if they had returned the ThyPRO (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u2009975) and\/or the 36-item Short Form Health Status survey questionnaire (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u2009964) and informed consent at follow-up. Scores from ThyPRO were compared to scores from a general population sample (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u2009712) using multiple linear regression adjusting for age and sex as well as multiple testing. Treatment-related QoL outcome for ATD, RAI, and surgery were compared, including adjustment for the number of treatments received, sex, age, and comorbidity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Regardless of treatment modality, patients with GD had worse thyroid-related QoL 6\u201310 years after diagnosis compared to the general population. Patients treated with RAI had worse thyroid-related and general QoL than patients treated with ATD or thyroidectomy on the majority of QoL scales. Sensitivity analyses supported the relative negative comparative effects of RAI treatment on QoL in patients with hyperthyroidism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>GD is associated with a lower QoL many years after treatment compared to the general population. In a previous small randomized controlled trial, no difference was found in patient satisfaction years after ATD, RAI, or surgery. Now, it is reported that in a large non-randomized cohort, patients who received RAI had adverse scores on ThyPRO and 36-item Short Form Health Status survey. These findings in a Swedish population are limited by comparison to normative data from Denmark, older age, and possibly a more prolonged course in those patients who received RAI, and a lack of information regarding thyroid status at the time of evaluation. The way RAI may adversely affect QoL is unknown, but since the results may be important for future considerations regarding treatment options for GD, they need to be substantiated in further studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/thy.2018.0315","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T10:45:17Z","timestamp":1548153917000},"page":"322-331","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":94,"title":["Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey"],"prefix":"10.1177","volume":"29","author":[{"given":"Ove","family":"T\u00f6rring","sequence":"first","affiliation":[{"name":"Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden."},{"name":"Division of Endocrinology, Department of Internal Medicine, S\u00f6dersjukhuset, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torquil","family":"Watt","sequence":"additional","affiliation":[{"name":"Department of Medical Endocrinology Rigshospitalet, Copenhagen, Denmark."},{"name":"Internal Medicine Herlev Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sj\u00f6lin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine and Health, \u00d6rebro University, \u00d6rebro, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Bystr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Hospital and \u00d6rebro University, \u00d6rebro, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirna","family":"Abraham-Nordling","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Calissendorff","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden."},{"name":"Department of Endocrinology, Metabolism, and Diabetes, Karolinska University Hospital, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Karkov","family":"Cramon","sequence":"additional","affiliation":[{"name":"Department of Medical Endocrinology Rigshospitalet, Copenhagen, Denmark."},{"name":"Internal Medicine Herlev Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Filipsson Nystr\u00f6m","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, G\u00f6teborg, Sweden."},{"name":"Department of Endocrinology, Sahlgrenska University Hospital, G\u00f6teborg, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Hallengren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5ne University Hospital, Malm\u00f6, Sweden."},{"name":"Department of Clinical Sciences, Lund University, Malm\u00f6, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Holmberg","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, G\u00f6teborg, Sweden."},{"name":"ANOVA, Karolinska University Hospital, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selwan","family":"Khamisi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Uppsala University Hospital, Uppsala, Sweden."},{"name":"Institution of Internal Medicine, Uppsala University, Uppsala, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Lantz","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5ne University Hospital, Malm\u00f6, Sweden."},{"name":"Department of Clinical Sciences, Lund University, Malm\u00f6, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Wallin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Faculty of Medicine and Health, \u00d6rebro University, \u00d6rebro, Sweden."},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510030"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0548"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60782-4"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-014-0097-2"},{"key":"e_1_3_3_6_2","first-page":"2986","article-title":"Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine\u2014a prospective, randomized study","volume":"81","author":"Torring O","year":"1996","unstructured":"Torring O, , Tallstedt L, , Wallin G, , Lundell G, , Ljunggren JG, , Taube A, , Saaf M, , Hamberger B, , Sjoberg HE, , Thoren M, , Alinder I, , Farnebo LO, , Blomgren H, , Hall P, , Tengroth B, , Lowhagen T, , Norberg R, , Curstedt T. 1996. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine\u2014a prospective, randomized study. J Clin Endocr Metab, 81:2986\u20132993.","journal-title":"J Clin Endocr Metab"},{"key":"e_1_3_3_7_2","article-title":"The long-term consequences of previous hyperthyroidism","volume":"62","author":"Brandt F","year":"2015","unstructured":"Brandt F. 2015. The long-term consequences of previous hyperthyroidism. A register-based study of singletons and twins. Dan Med J, 62.","journal-title":"Dan Med J"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.1.71"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2017.0029"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1998.8.653"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2005.15.1279"},{"key":"e_1_3_3_12_2","article-title":"The cure rate in first line treatment of Graves' disease in Sweden 7\u20139 years after diagnosis","volume":"25","author":"Wallin GK","year":"2015","unstructured":"Wallin GK, , Bystr\u00f6m K, , Sj\u00f6lin G, , T\u00f6rring O, , Khamisi S, , Holmberg M, , Abraham-Nordling M, , Calissendorff J, , Hallengren B, , Lantz J, , de Laval D, , Filipson H. 2015. The cure rate in first line treatment of Graves' disease in Sweden 7\u20139 years after diagnosis. Thyroid, 25:P177.","journal-title":"Thyroid"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1510549"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02124"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0044"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000365211"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2011.11.001"},{"key":"e_1_3_3_18_2","first-page":"283","article-title":"Quality of life and occupational disability in endocrine orbitopathy","volume":"106","author":"Ponto KA","year":"2009","unstructured":"Ponto KA, , Pitz S, , Pfeiffer N, , Hommel G, , Weber MM, , Kahaly GJ. 2009. Quality of life and occupational disability in endocrine orbitopathy. Dtsch Arztebl Int, 106:283\u2013289.","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0475"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01241.x"},{"key":"e_1_3_3_21_2","first-page":"368","article-title":"Quality of life in patients with Graves ophthalmopathy","volume":"103","author":"Yeatts RP","year":"2005","unstructured":"Yeatts RP. 2005. Quality of life in patients with Graves ophthalmopathy. Trans Am Ophthalmol Soc, 103:368\u2013411.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0877"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-014-0798-1"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-009-9460-8"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0069"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0521"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-9536(95)00125-Q"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0209"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0433"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00081-X"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/75.4.800"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000353777"},{"key":"e_1_3_3_34_2","unstructured":"NordicCo-operation. Available at: www.norden.org\/en (accessed December12 2017)."},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00107-3"},{"key":"e_1_3_3_36_2","unstructured":"Cohen J. 1988. Statistical Power Analysis for the Behavioral Sciences. Second edition. Lawrance Erlbaum Associates Hillsdale NJ."},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0450"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02336"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2802"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12688"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1159\/000443828"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199206253262603"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0747"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2130"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801083380201"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0837"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803123381103"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0753-4"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1999.00497.x"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2000.10.341"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1089\/105072502760043503"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.4.347"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2012-1030"},{"key":"e_1_3_3_54_2","first-page":"230","article-title":"Mortality in patients treated for hyperthyroidism with iodine-131","volume":"128","author":"Hall P","year":"1993","unstructured":"Hall P, , Lundell G, , Holm LE. 1993. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol, 128:230\u2013234.","journal-title":"Acta Endocrinol"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1874"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/11.3.218"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2321"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-13262-9"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.06.003"}],"container-title":["Thyroid\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/thy.2018.0315","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/thy.2018.0315","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/thy.2018.0315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:04:56Z","timestamp":1777586696000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/thy.2018.0315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1089\/thy.2018.0315"],"URL":"https:\/\/doi.org\/10.1089\/thy.2018.0315","relation":{},"ISSN":["1050-7256","1557-9077"],"issn-type":[{"value":"1050-7256","type":"print"},{"value":"1557-9077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}